CLINICAL_TRIALS
trial_result
· 2019-01-23
Clinical Trial Update: The Effects of RPL554 in Addition to Tiotropium in COPD Patients [Phase 2]
Summary
Phase 2 trial update evaluating the addition of RPL554 to tiotropium in COPD patients; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Verona Pharma plc | Conditions: Chronic Obstructive Pulmonary Disease Moderate | Phase 2 | Status: COMPLETED | Results posted: 2019-01-23